2026-2027 Basic and Clinical Science Course, Section 12

Retina and Vitreous
Updated coverage of retinal diseases blends revised insights into age?related macular degeneration, emerging gene therapies, and Chloroquine toxicity with new surgical videos, interactive activities and case studies. It equips residents, fellows and practitioners with streamlined guidance for clinical decision-making.
BCSC Section 12, Retina and Vitreous, of the Academy’s Basic and Clinical Science Course (BCSC) provides essential, relevant guidance on diagnosing and managing vitreoretinal disease. Designed for ophthalmology residents, fellows, and practicing ophthalmologists, this comprehensive resource supports both exam preparation and real-world decision-making.

Notable Revisions to BCSC Section 12 include:

• Expanded updates of age-related macular degeneration (AMD), including newly approved therapies such as intravitreal complement inhibitor medications (sample)
• Reorganized chapters